CIK 0001582554 · Non-accelerated filer<br>Smaller reporting company
Matinas BioPharma Holdings, Inc.
Sign in to watch- Ticker
- MTNB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463011414
- Phone
- 908-484-8805
- Business address
- 1545 ROUTE 206 SOUTH, SUITE 302, BEDMINSTER, NJ, 07921
- 4 Grant or award Director acquired 38,066 shares (grant or award)
- 4 Grant or award Director acquired 25,179 shares (grant or award)
- 4 Conversion Director acquired 200,000 shares (conversion)
- 4 Grant or award Director acquired 29,739 shares (grant or award)
- DEF 14A Proxy Proxy Statement
- UPLOAD Other SEC-generated Letter
- PRER14A Other PRER14A
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Open-market buy Director bought 20,000 shares at $0.66 ($13,200)
- 4 Open-market buy President and CEO bought 14,650 shares at $0.68 ($9,975)
- 4 Open-market buy Director bought 20,000 shares at $0.68 ($13,650)
- 4 Open-market buy Director bought 10,400 shares at $0.70 ($7,268)
- 4 Open-market buy Director bought 100,000 shares at $0.72 ($71,850)
- 8-K Event Results of operations · Regulation FD disclosure
- 10-Q Report Quarterly Report
- 4 Grant or award Director acquired 21,879 shares (grant or award)
- 4 Grant or award Director acquired 18,524 shares (grant or award)
- 4 Grant or award Director acquired 28,005 shares (grant or award)
Page 17 of 29 · 576 filings